Revised Draft v2.0 Esperion ESPR Dives 20 in Response to Lackluster Label for PCSK9 Drug Approval

On Thursday July 24 Praluent a PCSK9 inhibitor from Regeneron Sanofi was approved by the FDA. This was no surprise. We expected this drug to receive approval.It was approved for use in addition to diet and maximally tolerated statin therapy in adult patie...